GE Healthcare announces the launch of the Human Fab Capture Kit for the reliable and rapid screening and characterisation of human Fab antibody fragments with Biacore instruments.
The kit is suitable for use with samples such as crude cell lysates, periplasmic extracts or purified Fab fragments.
The rapid and reliable selection of the Fab fragments is ensured by a broad specificity for human Fab fragments, combined with a high capture efficiency and stability, providing excellent assay performance, according to GE Healthcare.
The pre-optimised assay for this kit delivers resource, cost and time savings as it eliminates the need to find and identify suitable reagents, and minimises assay development and verification.
In addition, there is only a minimal need for adjustments between projects due to antigen-independent immobilisation and regeneration conditions.
The Human Fab Capture Kit contains Human Fab Binder and immobilisation buffer for 10 immobilisations and regeneration solution for 1,000 regeneration injections when used with Biacore T100 and Biacore A100.
